ESGCT '23 Lunch Symposium | Minicircles: next-generation gene vectors with high potential for clinical applications
Join our ESGCT Lunchtime Symposium OCT 26
Why is PlasmidFactory’s minicircle so awesome?
Get more answers at the ESGCT in Brussels from our invited speakers experienced in the application:
Univ. -Prof. Dr. med. Michael Hudecek, University Hospital, Würzburg, Germany
Advanced strategies for gene transfer and gene editing in CAR-T cells
Dr. Kathrin Teschner, Sartorius Xell GmbH, Schloss Holte-Stukenbrock, Germany
Use of minicircles for the production of AAV in HEK293 cells
Dr. Thijs Gerritzen, Amarna Therapeutics, Leiden, The Netherlands.
Generation of a new, re-dosable, SV40 viral vector based on minicircle DNA
Chairs:
Dr. Daniel Scherman, Université Paris Descartes, Paris, France
Dr. Martin Schleef, PlasmidFactory GmbH, Bielefeld, Germany
ESGCT programme:
https://www.esgctcongress.com/programme-thu
